Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    men's health

    Penile cancer

    Also known as: Cancer of the penis, Penile carcinoma, Penile malignancy, Penile squamous cell carcinoma

    Penile cancer refers to malignancy involving the penile tissues, predominantly squamous cell carcinoma. Diagnosis and management necessitate specialist urological assessment, histopathological biopsy, and clinical staging. Regional lymph node assessment can influence management. Current literature, including a proposed neoadjuvant trial, HPV awareness surveys, and preliminary surgical data, provides no evidence that acupuncture or herbal medicine are efficacious primary or adjuvant treatments for penile cancer or its specific sequelae. In clinical practice, Traditional Chinese Medicine (TCM) may serve as an adjunctive framework for managing fatigue, psychological distress, and gastrointestinal dysfunction; however, TCM patterns must not be utilised to assess tumour staging or prognosis. Supportive interventions must be coordinated with the multidisciplinary oncology team, particularly regarding surgical recovery, lymphatic complications, and systemic therapies. The traditional protocols listed are for practitioner reference and do not constitute antineoplastic prescriptions.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Adhere strictly to post-operative wound and genital hygiene protocols as directed by the surgical team; refrain from applying non-prescribed topical agents or irritants to the affected site.
    • •Maintain consistent nutritional and fluid intake and report unintentional weight loss; consider dietetic referral if nutritional status is compromised.
    • •Integrate rest with appropriate physical activity, adhering to post-inguinal surgery mobility restrictions, and seek clinical advice for new-onset lower limb swelling.
    • •Engage with the medical team regarding sexual health, smoking cessation, and HPV vaccination; note that vaccination serves as a primary preventive measure rather than a therapeutic intervention for established malignancy.

    Cautions & Contraindications

    See sources
    • •Do not needle the penile lesion, groin surgical field, drains, open wounds or areas of suspected recurrence. Obtain surgical clearance before considering needling near treated regions. These are precautionary extensions of the surgical context, not acupuncture findings from these studies.[,]
    • •Avoid needling a swollen or lymphoedematous limb; after inguinal node procedures, obtain specialist advice about lower-limb needling even without visible swelling. The supplied study reports lymphatic complications but does not evaluate needling safety.[]
    • •Do not commence herbal formulas alongside investigational anticancer treatment without oncology and pharmacy approval. The supplied trial protocol establishes neither herb–drug compatibility nor safety of adjunctive acupuncture; clinically significant cytopenias or suspected infection require treatment-team review before needling.[]

    When to reassess or seek care again

    See sources

    Record baseline fatigue, nausea, distress and sleep difficulty on 0–10 scales, alongside weight and functional activity. Review any agreed supportive intervention within 1–2 weeks and after each oncology treatment change. Stop and reassess for worsening symptoms or adverse effects; refer for persistent poor intake, weight loss or declining function. If no meaningful patient-reported benefit after 2–4 weeks, discontinue or revise the adjunctive plan. Tumour response remains the responsibility of the oncology team.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Future oncology (London, England) · 2026
    2. Human vaccines & immunotherapeutics · 2026
    3. World journal of surgical oncology · 2025
    4. Annals of medicine · 2025

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.